John, does this ruling does it change anything in your outlook. Not at all. If if anything, when you get get an announcement like this, you've gotta consider that you you've got players on both sides of the trading floors essentially making decisions related to changing positions, repositioning, adding the positions.This this this will this has to be baked in and then considered what will actually happen. And as as you all mentioned, it will take a while for this to take effect, and then the response is lik ...

Company Overview - CRA International (CRAI) shares increased by 5.9% to close at $188.94, following a notable trading volume that exceeded typical levels, contrasting with an 11.1% loss over the past four weeks [1] - The stock is experiencing positive momentum due to a market shift towards high-quality consulting firms amid improving investor sentiment [1] Earnings Expectations - CRA is projected to report quarterly earnings of $2.05 per share, reflecting a year-over-year increase of 1%, with revenues expected to reach $190.02 million, a 7.7% rise from the same quarter last year [2] - The stability of the consensus EPS estimate for CRA over the past 30 days suggests that the stock's price may not continue to rise without corresponding trends in earnings estimate revisions [3] Industry Context - CRA is part of the Zacks Consulting Services industry, where another company, Stantec (STN), saw its stock decrease by 1.9% to $99.08, despite a 7.1% return over the past month [3] - Stantec's consensus EPS estimate has increased by 0.7% over the past month to $0.87, indicating a 10.1% growth compared to the previous year, and it currently holds a Zacks Rank of 2 (Buy) [4]

Core Insights - Metro Inc. is a significant player in the Canadian retail and food industry, operating supermarkets, discount stores, and pharmacies, and competes with major retailers like Loblaw Companies and Sobeys [1] Financial Performance - BMO Capital maintained an "Outperform" rating for Metro Inc. (MTRAF) while adjusting the price target from C$115 to C$110, with the stock price at $68.73, reflecting a slight increase of 0.37% [2] - The recent Q1 2026 earnings call highlighted the company's financial health, discussing earnings, revenue growth, and strategic plans, with the stock price showing stability within the trading range [3] Market Position - MTRAF has a 52-week high of $78.73 and a low of $62.30, indicating volatility over the past year, with a market capitalization of approximately $14.7 billion [4] - The trading volume for MTRAF is 627 shares, making it a stock of interest for investors in the retail sector [4]

Company Overview - Profound Medical (PROF) shares increased by 9.5% to close at $8.34, with trading volume significantly higher than usual, contrasting with a 0.3% loss over the past four weeks [1] - The rise in share price followed the successful treatment of a prostate cancer patient at Mount Sinai Hospital using the TULSA-PRO system, which integrates advanced technologies for treatment [2] Financial Performance - The company is projected to report a quarterly loss of $0.28 per share, reflecting a year-over-year decline of 40%, while revenues are expected to reach $8 million, marking a 91.4% increase from the previous year [3] - The consensus EPS estimate for the upcoming quarter has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] Industry Context - Profound Medical operates within the Zacks Medical - Drugs industry, where Rigel Pharmaceuticals (RIGL) also holds a Zacks Rank of 3 (Hold) and has seen a 3.4% decrease in its share price [4][5] - Rigel's consensus EPS estimate for its upcoming report is $1.17, representing a 46.3% increase from the previous year, with its stock also experiencing a decline of 6.7% over the past month [5]

Core Viewpoint - PennyMac Financial (PFSI) shares experienced a significant rally of 6.4%, closing at $146.19, driven by higher trading volume and positive investor sentiment following President Trump's announcement regarding mortgage-backed securities [1][2]. Company Performance - The company is projected to report quarterly earnings of $3.23 per share, reflecting a year-over-year increase of 12.2%, with expected revenues of $599.02 million, up 27.4% from the previous year [3]. - However, the consensus EPS estimate for the quarter has been revised 1.4% lower in the last 30 days, indicating a negative trend in earnings estimate revisions, which typically does not correlate with price appreciation [4]. Industry Context - PennyMac operates within the Zacks Financial - Mortgage & Related Services industry, which is currently seeing increased investor confidence due to anticipated lower mortgage rates that could enhance loan originations and refinancing activities [2]. - Another company in the same industry, Tree.com (TREE), saw a 12.9% increase in its stock price, closing at $62.91, although it has returned -0.4% over the past month [4].

Company Overview - Five Star Bancorp (FSBC) shares increased by 5.1% to $34.9 in the last trading session, supported by higher-than-average trading volume [1] - The stock has experienced a rally for four consecutive trading sessions, benefiting from a sector-wide gain due to global risk-on sentiment and a rebound in banking stocks [1] Earnings Expectations - FSBC is expected to report quarterly earnings of $0.71 per share, reflecting a year-over-year increase of 36.5% [2] - Revenue projections for FSBC stand at $40.15 million, which is a 26.4% increase compared to the same quarter last year [2] Stock Performance and Trends - The consensus EPS estimate for FSBC has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without earnings estimate revisions [3] - FSBC currently holds a Zacks Rank of 2 (Buy), suggesting positive sentiment towards the stock [3] Industry Comparison - Five Star Bancorp is part of the Zacks Banks - West industry, where Bank of Hawaii (BOH) has a Zacks Rank of 3 (Hold) and reported a 0.1% decline in its last trading session [3][4] - BOH's consensus EPS estimate is $1.13, representing a year-over-year change of 21.5% [4]

Group 1 - Perimeter Solutions, SA (PRM) shares increased by 8.5% to close at $15.27, with a notable trading volume, and a total gain of 13.5% over the past four weeks [1] - The company has opened a new PHOS-CHEK facility in McClellan Park, Sacramento, CA, which is one of the most advanced fire-retardant production facilities globally, covering an area of 110,000 square feet [2] - This new facility will produce three key fire retardants: PHOS-CHEK MVP-Fx, PHOS-CHEK 259-Fx, and PHOS-CHEK LCE20-Fx, bringing the total number of PHOS-CHEK production facilities to seven across the U.S. and Canada [3] Group 2 - Perimeter Solutions is expected to report quarterly earnings of $0.28 per share, reflecting a year-over-year increase of 100%, with revenues projected at $133.75 million, up 5.1% from the previous year [4] - The consensus EPS estimate for Perimeter Solutions has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [5] - Perimeter Solutions holds a Zacks Rank of 2 (Buy), indicating positive market sentiment, while another company in the same industry, CSW Industrials, has seen a slight decline in stock price [5]